Ruud Dobber, AstraZeneca
If you were a cancer patient, where would you rather be — the United States or Europe?
LONDON — Frustrated by the lack of legislation implemented to lower soaring drug prices in the United States — a key issue that has elicited outrage …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
